NeoMetrics, Inc.

NeoMetrics, Inc.

2605 Fernbrook Ln. N., Ste. J
Plymouth, Minnesota 55447
Phone: 763-559-4440
About the Company

Since 2001, NeoMetrics has been delivering high performance guidewires, with over 10 years of consecutive growth. In 2012, our Minneapolis, Minnesota production facility was joined by our newest operation in Santa Ana, Costa Rica. The combined capabilities of our two state of the art facilities assures excellence in both product design and cost effective manufacturing.

Our Mission:To be the premier supplier of OEM guidewires, components and wire-based medical devices to the medical device industry by delivering the highest quality products that enhance clinical performance and improve supply chain management.

Full spectrum of clinical applications

NeoMetrics works in a variety of clinical disciplines to provide our customers with product design insights that optimize guidewire performance. Our staff of experienced medical device professionals combined with our strong clinical knowledge, state of the art testing capabilities, regulatory knowledge and process technology expertise delivers leading edge results. Specialty/Procedural A complete line of guidewires for vascular access and PICC procedures. Peripheral/Vascular Proven experience with a wide variety of interventional radiology designs and procedures. Interventional Cardiology The premier partner in design testing and manufacturing of interventional cardiology guidewires. Gastrointestinal/endoscopy* Jacketed wire design capabilities for biliary and endoscopic procedures. Neuroradiology* Expertise to design and manufacture small diameter wires for embolotherapy and stroke management. We also specialize in custom guidewire applications for the newest procedures. Interested in designing your own custom guidewire? Try the interactive “build a guidewire” feature on our website. http://www.neometricsinc.com/guidewire.html We’ll contact you shortly to discuss bringing your design needs to completion. *Guidewires for applications in this market segment will require regulatory considerations.